Overview

Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer

Status:
Completed
Trial end date:
2020-10-08
Target enrollment:
Participant gender:
Summary
This is a multi-institutional, single arm, open-label, phase II study, including a safety run-in cohort. No randomization or blinding involved.
Phase:
Phase 2
Details
Lead Sponsor:
Hoosier Cancer Research Network
Safi Shahda, M.D.
Collaborators:
Hoosier Cancer Research Network
Merck Sharp & Dohme Corp.
Treatments:
Pembrolizumab